Abridge vs Commure (2026)
If your failure mode is buying the enterprise scribe that does revenue cycle too without asking how each got there, this is the pair that separates organic depth from assembled breadth. Abridge built outward from a documentation core: the strongest evidence in the category, a Kaiser study of 1,306 clinicians in NEJM AI plus Best in KLAS in 2025 and 2026, the deepest Epic integration in the index with native bidirectional sync, and Linked Evidence that maps every generated sentence back to the source audio. Commure assembled the same surface area by acquisition, rolling up Athelas, Augmedix, and Memora into ambient documentation that flows into autonomous coding, CDI, and claims, with broad reach across 50 plus EHRs and explicit human review tiers. One earned the footprint and can prove it. The other bought the footprint and bundles it.
- The strongest evidence in the category: a Kaiser Permanente study of 1,306 clinicians published in NEJM AI, independently corroborated by Best in KLAS for Ambient AI in both 2025 and 2026, which is buyer survey based rather than vendor asserted.
- The deepest EHR integration in the index: embedded natively across Epic Haiku, Canto, and Hyperdrive with bidirectional note sync rather than a parallel interface, plus an athenahealth partnership and real time prior authorization.
- The most rigorous oversight in the category: Linked Evidence maps every part of a generated note back to the source audio, so a clinician can verify any sentence against what was actually said before signing.
- One vendor for the whole revenue cycle adjacent stack: Commure rolls up Athelas, Augmedix, and Memora so ambient documentation flows into autonomous coding, CDI, and claims under a single contract, with Vizient negotiated access for member systems.
- Human review built in as a product tier rather than an afterthought: Go is AI only, Assist adds specialist review, and Live is synchronous human documentation, so a buyer can dial the level of human involvement per use case.
- Broad EHR reach beyond Epic: Augmedix Go is documented across more than 50 systems including Oracle Health and MEDITECH, across ambulatory and acute settings.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abridge and Commure are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abridge | Commure |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2018 | 2017 |
| Headquarters | Pittsburgh, Pennsylvania | Mountain View, California |
| Website | abridge.com | commure.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Abridge its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Set against Commure, Abridge grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Commure its top capability grade on AI Centrality. Set against Abridge, Commure does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose Abridge or Commure?
The AI Health Index grades Abridge higher than Commure on every axis that separates them, several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Commure does not grade higher on any scored axis.
Where do Abridge and Commure differ most?
The widest separation the AI Health Index records between Abridge and Commure is on Model Supply Chain Disclosure, where Abridge grades A and Commure grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Abridge and Commure grade the same?
The AI Health Index grades Abridge and Commure the same on several axes, including AI Centrality, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Abridge and Commure not disclosed?
At the last review, at least one of Abridge and Commure published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
The two are assessed to different depth, so read the grades accordingly. Abridge carries A across its assessed axes (AI centrality, evidence, autonomy, EHR, setting); Commure sits at B across security, HIPAA, PHI, EHR, setting, and autonomy and has no clinical evidence axis graded, so its documentation evidence is unassessed here rather than weak.
Neither publishes pricing; both are contact the vendor, with a third party estimate of roughly 2,500 dollars per clinician per year recorded for Abridge. Commure's SOC 2 Type 2 reference attaches to its data centers rather than to Commure itself, and its PHI language does not state whether data trains models. As with every ambient scribe, speech models carry documented accuracy variation across accent and dialect.